CAC vs PHAR

Comparison between Camden National Corp (CAC, Company) and Pharming Group N.V. (PHAR, Company).

CAC is from the Financial Services sector, while PHAR is from the Healthcare sector.

5-Year PerformanceCAC has outperformed PHAR, delivering a return of +8.1% compared to +2.9%

CAC vs PHAR - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	CAC(COMPANY)	PHAR(COMPANY)
Market Cap	$907M	$909M
Max Drawdown	66.92%	60.45%
Sharpe Ratio	0.95	0.73
5Y Beta	0.82	0.63
Industry	Banks - Regional	Biotechnology
P/E Ratio	11.38	72.56
Forward P/E	10.25	23.09
PEG Ratio	0.23	N/A
Dividend Yield	3.10%	N/A
5Y Dividends CAGR	8.76%	N/A
5Y EPS CAGR	1.36%	-19.96%
Debt to Equity	72.31%	43.21%
Free Cash Flow Yield	8.51%	5.51%
P/S Ratio	3.68	2.48
P/B Ratio	1.29	3.45

Market Cap

CAC

$907M

Winner

PHAR

$909M

Max Drawdown

CAC

66.92%

Winner

PHAR

60.45%

Sharpe Ratio

Winner

CAC

0.95

PHAR

0.73

5Y Beta

CAC

0.82

Winner

PHAR

0.63

Industry

CAC

Banks - Regional

PHAR

Biotechnology

P/E Ratio

Winner

CAC

11.38

PHAR

72.56

Forward P/E

Winner

CAC

10.25

PHAR

23.09

PEG Ratio

CAC

0.23

PHAR

N/A

Dividend Yield

CAC

3.10%

PHAR

N/A

5Y Dividends CAGR

CAC

8.76%

PHAR

N/A

5Y EPS CAGR

Winner

CAC

1.36%

PHAR

-19.96%

Debt to Equity

CAC

72.31%

Winner

PHAR

43.21%

Free Cash Flow Yield

Winner

CAC

8.51%

PHAR

5.51%

P/S Ratio

CAC

3.68

Winner

PHAR

2.48

P/B Ratio

Winner

CAC

1.29

PHAR

3.45

CAC vs PHAR - Historical Returns

Returns include dividend reinvestment.

Period	CAC	PHAR
1 month	+2.34%	+2.33%
3 months	+8.29%	-20.85%
6 months	+19.55%	-33.15%
1 year	+32.77%	+30.40%
5 years(CAGR)	+8.15%	+2.89%
10 years(CAGR)	+9.87%	N/A
Max(CAGR)	+9.09%	-4.17%

Winner

CAC

+2.34%

PHAR

+2.33%

Winner

CAC

+8.29%

PHAR

-20.85%

Winner

CAC

+19.55%

PHAR

-33.15%

Winner

CAC

+32.77%

PHAR

+30.40%

5Y(CAGR)

Winner

CAC

+8.15%

PHAR

+2.89%

10Y(CAGR)

CAC

+9.87%

PHAR

N/A

Max(CAGR)

Winner

CAC

+9.09%

PHAR

-4.17%

CAC vs PHAR - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	CAC	PHAR
2026	+27.74%	-23.16%
2025	+7.08%	+68.93%
2024	+18.51%	-12.49%
2023	-5.35%	-0.70%
2022	-12.38%	+24.49%
2021	+38.17%	-40.08%
2020	-19.25%	-9.01%
2019	+30.40%	N/A
2018	-12.99%	N/A
2017	-2.16%	N/A
2016	+58.32%	N/A
2015	+16.15%	N/A
2014	-0.53%	N/A
2013	+17.07%	N/A
2012	+0.50%	N/A
2011	-9.19%	N/A
2010	+11.32%	N/A
2009	+27.52%	N/A
2008	-0.97%	N/A
2007	-35.95%	N/A
2006	+44.43%	N/A
2005	-14.84%	N/A
2004	+34.42%	N/A
2003	+27.06%	N/A
2002	+34.76%	N/A
2001	+45.65%	N/A
2000	-8.52%	N/A
1999	-11.84%	N/A

CAC vs PHAR Drawdown Comparison

The maximum drawdown for CAC was -64.60%, occurring on Mar 9, 2009. Recovery took 1388 trading sessions.

The maximum drawdown for PHAR was -60.45%, occurring on Jun 16, 2022. Recovery took 1225 trading sessions.

The current CAC drawdown is -3.58%. The current PHAR drawdown is -37.82%.

Rank	CAC	PHAR
#1	-64.60% Dec 28, 2006 - Jul 3, 2012	-60.45% Dec 23, 2020 - Nov 10, 2025
#2	-43.56% Jan 7, 2022 - Nov 6, 2024	-43.34% Jan 27, 2026 - May 7, 2026
#3	-43.46% Feb 5, 2020 - Mar 8, 2021	-10.93% Nov 26, 2025 - Dec 12, 2025
#4	-37.51% Nov 5, 1999 - Jul 31, 2001	-10.03% Nov 10, 2025 - Nov 13, 2025
#5	-27.22% Jun 21, 2018 - May 3, 2019	-9.70% Nov 13, 2025 - Nov 26, 2025
#6	-25.97% Nov 6, 2024 - Jan 21, 2026	-9.45% Dec 12, 2025 - Dec 24, 2025
#7	-22.20% Dec 14, 2004 - Aug 2, 2005	-7.08% Dec 24, 2025 - Jan 9, 2026
#8	-21.61% Jun 24, 2002 - Jun 30, 2003	-4.58% Jan 12, 2026 - Jan 22, 2026
#9	-20.69% Jul 3, 2012 - Jul 16, 2013	-1.15% Jan 22, 2026 - Jan 26, 2026
#10	-19.83% Nov 29, 2013 - Nov 3, 2015	N/A
#11	-18.69% Aug 9, 2001 - Jan 7, 2002	N/A
#12	-17.50% Sep 12, 2005 - Apr 21, 2006	N/A
#13	-16.39% Dec 7, 2015 - Jul 13, 2016	N/A
#14	-16.25% Mar 5, 2004 - Sep 28, 2004	N/A
#15	-16.15% Dec 21, 2016 - Oct 20, 2017	N/A